Clinical Trial Update: This Is An Open-Label Study To Evaluate Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive Bladder

View source ↗

Summary

An open-label study evaluating fesoterodine plus a patient support plan in patients with overactive bladder has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Fesoterodine (fesoterodine)

Snippet

Sponsor: Pfizer | Conditions: Overactive Bladder | Status: COMPLETED | Results posted: 2012-03-15